Investors
AI has collapsed the cost of writing software. It has not collapsed the cost of trusting it — and in healthcare, trust was always the expensive part: encryption, access control, audit trails, change control, the evidence an auditor asks for. We build the layer that makes custom software consumable inside a health system, and we sell it as one governed, operated platform.
Health systems carry dozens of point-solution contracts for mostly-generic software, years-long internal backlogs, and an ungoverned shadow layer of spreadsheets holding data nobody audits. That is one problem, not three: governed custom software has been too expensive for the long tail of hospital needs.
Code generation commoditizes; governance compounds. The durable business is not AI writing healthcare apps — it is the rails underneath them: one operated instance per institution, every decision recorded, every tool inheriting the security architecture, with honest exit rights.
By default, apps built on the platform persist no patient data — the customer's EHR remains the system of record. While the market sells “put your data in us safely,” we sell the opposite, and health-system compliance offices notice the difference.
Deliberately. The company is early-stage and privately held, led by a practicing clinician, and built governance-first: the security architecture, the compliance documentation, and the copy discipline you can read on our security page — where we tell you what we don't claim — all predate our first customer. We think that ordering is the moat, and we run the company the way the product runs: plain claims, recorded decisions, no adjectives where evidence belongs.
We share a detailed memorandum — the market logic, the business model, the plan, and an honest risk section — with prospective investors in direct conversation. If that's you, write to us and tell us who you are.
[CONTACT EMAIL — pending]